Related Experiment Video
Updated: Jun 2, 2026

A Murine Model of Irreversible and Reversible Unilateral Ureteric Obstruction
Published on: December 20, 2014
Irreversible Kidney Damage due to Multicentric Castleman's Disease
Fredrik Kahn1, Anna Fagerström, Mårten Segelmark
1Department of Infectious Disease.
Insights
This study details a rare multicentric Castleman
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Castleman's Disease (CD) is a rare lymphoproliferative disorder.
- Diagnosis requires lymph node biopsy, with three known histologic variants.
- Systemic inflammation is a common feature of CD.
Purpose of the Study:
- To report a case of multicentric Castleman's disease, plasma cell variant.
- To highlight the association with systemic amyloidosis and negative HHV-8 status.
- To discuss treatment outcomes and irreversible complications.
Main Methods:
- Histopathological examination of lymph node tissue.
- Clinical case presentation and review.
- Treatment with cytotoxic drugs and anti-CD20 antibody therapy.
Main Results:
- A case of multicentric Castleman's disease, plasma cell variant, negative for HHV-8, was identified.
- The patient presented with systemic amyloidosis, a complication previously associated with localized CD.
- Long-term remission of CD was achieved, but nephrotic syndrome persisted.
Conclusions:
- Multicentric Castleman's disease can present with systemic amyloidosis, irrespective of CD type.
- Treatment with cytotoxic agents and anti-CD20 antibodies can induce clinical remission.
- Amyloidosis-related complications like nephrotic syndrome may remain irreversible despite CD treatment.
Abstract:
Castleman's Disease (CD) is a rare lymphoproliferative disorder accompanied by marked systemic inflammatory response. Morphological diagnosis of CD requires biopsy of the whole of the involved lymph node tissue. Three histologic variants have already been described in CD morphology (hyaline vascular, plasma-cell, and mixed). In this study, we report a case of a multicentric Castleman's disease of the plasma cell variant type with negative Herpes Virus 8. The clinical presentation of this patient was of systemic amyloidosis as a result of both a delayed diagnosis and medical management. Previously described cases of CD with secondary amyloidosis have been of the localized type. Regardless, long-standing clinical remission of CD by cytotoxic drugs and anti-CD20 antibody therapy was achieved, but the nephrotic syndrome remained irreversible.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Chronic Kidney Disease I: Introduction
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
Diabetic Nephropathy
